Clinical Trial Update: A Study of IPL344 in the Treatment of ALS Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that IPL344 for amyotrophic lateral sclerosis is in Phase 1/Phase 2 but has been suspended. The sponsor is Immunity Pharma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• IPL344

Snippet

Sponsor: Immunity Pharma Ltd. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: SUSPENDED